文献速递重症综合管理与镇静镇痛

量身定制的多组分方案减少危重患者不适感:整群随机对照试验

A tailored multicomponent program to reduce discomfort in critically ill patients: a cluster-randomized controlled trial.
PubMed 文献 · Intensive Care Med · 2017-11-27
一句话结论在34个法国成人ICU中,实施6个月量身定制多组分方案使IPREA总体不适评分较对照组降低7.00分(95%CI -9.89至-4.11,p<0.001)。

该整群随机对照试验纳入34个法国成人ICU,随机分为实验组(17个ICU,先实施6个月方案再6个月不实施)和对照组(17个ICU,顺序相反)。方案包括评估ICU相关自我感知不适、即时和每月反馈给医疗团队、以及站点特异性定制干预。主要终点为IPREA问卷(16条目,0为最小不适,100为最大总体不适)的总体不适评分,于ICU出院当天填写,时间范围为ICU入院至出院。结果显示实验组398例、对照组360例患者,总体不适评分组间差异为-7.00(95%CI -9.89至-4.11,p<0.001),调整年龄、性别、ICU时长、机械通气时长和入院类型后差异为-6.35(SE 1.23,p<0.001),16个条目中12个条目也显示方案效果。结论为该方案降低成人危重患者自我感知不适。

要点

  • 在34个法国成人ICU中,实施量身定制多组分方案使IPREA总体不适评分较对照组降低7.00分(95%CI -9.89至-4.11,p<0.001)。
  • 调整年龄、性别、ICU时长、机械通气时长和入院类型后,方案对总体不适评分仍有正面效果(差异-6.35,SE 1.23,p<0.001)。
  • 16个IPREA条目中有12个条目显示方案效果。
  • 方案包括评估ICU相关自我感知不适、即时和每月反馈给医疗团队、以及站点特异性定制干预。
  • IPREA问卷于ICU出院当天填写,时间范围为ICU入院至出院。

适用人群与场景

  • 法国成人ICU患者,来自34个无计划减少不适干预的ICU,实验组398例、对照组360例。

处置流程与药物剂量

  • 实验组ICU实施6个月量身定制多组分方案,包括评估ICU相关自我感知不适、即时和每月反馈给医疗团队、以及站点特异性定制干预;随后6个月不实施方案。
  • 对照组ICU顺序相反:先6个月不实施方案,再6个月实施方案。
  • IPREA问卷于ICU出院当天填写,时间范围为ICU入院至出院。

研究设计与关键结果

  • 整群随机对照试验,34个法国成人ICU随机分为实验组17个和对照组17个,实验组398例、对照组360例患者。
  • 主要终点IPREA总体不适评分组间差异(实验组减对照组)为-7.00(95%CI -9.89至-4.11,p<0.001)。
  • 调整年龄、性别、ICU时长、机械通气时长和入院类型后,总体不适评分差异为-6.35(SE 1.23,p<0.001)。
  • 16个IPREA条目中有12个条目显示方案效果。

证据类型、等级与局限

  • 证据类型:整群随机对照试验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为该量身定制多组分方案可降低成人危重患者自我感知不适。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

PURPOSE: Critically ill patients are exposed to stressful conditions and experience several discomforts. The primary objective was to assess whether a tailored multicomponent program is effective for reducing self-perceived discomfort.

METHODS: In a cluster-randomized two-arm parallel trial, 34 French adult intensive care units (ICUs) without planned interventions to reduce discomfort were randomized, 17 to the arm including a 6-month period of program implementation followed by a 6-month period without the program (experimental group), and 17 to the arm with an inversed sequence (control group). The tailored multicomponent program consisted of assessment of ICU-related self-perceived discomforts, immediate and monthly feedback to healthcare teams, and site-specific tailored interventions. The primary outcome was the overall discomfort score derived from the 16-item IPREA questionnaire (0, minimal, 100, maximal overall discomfort) and the secondary outcomes were the discomfort scores of each IPREA item. IPREA was administered on the day of ICU discharge with a considered timeframe from the ICU admission until ICU discharge.

RESULTS: During a 1-month assessment period, 398 and 360 patients were included in the experimental group and the control group, respectively. The difference (experimental minus control) of the overall discomfort score between groups was - 7.00 (95% CI - 9.89 to - 4.11, p < 0.001). After adjustment (age, gender, ICU duration, mechanical ventilation duration, and type of admission), the program effect was still positive for the overall discomfort score (difference - 6.35, SE 1.23, p < 0.001) and for 12 out of 16 items.

CONCLUSIONS: This tailored multicomponent program decreased self-perceived discomfort in adult critically ill patients.

TRIAL REGISTRATION: Clinicaltrials.gov Identifier NCT02442934.

来源:Intensive Care Med,查看原文。版权归原作者所有。

参考来源

  1. Kalfon P, Baumstarck K, Estagnasie P, et al. A tailored multicomponent program to reduce discomfort in critically ill patients: a cluster-randomized controlled trial. Intensive Care Med. 2017. PMID: 29181557. doi:10.1007/s00134-017-4991-x

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。